StockData
GoodRx Holdings, Inc. logo

GoodRx Holdings, Inc. (GDRX) stock

GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3037% below fair value
$3.47−0.04 (-1.14%)

Close on Nov 17, 2026Market cap $1.18BP/E 86.8Yield –

GoodRx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

GoodRx's price to sales ratio was 1.6× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.8× to 19.5×, with a median of 2.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.6×+0.4
2025Dec 31, 20251.2×−1.0
2024Dec 31, 20242.3×−1.5
2023Dec 29, 20233.8×+1.4
2022Dec 30, 20222.3×−17.1
2021Dec 31, 202119.5×+0.8
2020Dec 31, 202018.7×–

More GoodRx figures

See a number that looks wrong?